298 related articles for article (PubMed ID: 29472195)
1. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
[TBL] [Abstract][Full Text] [Related]
2. Gastro-oesophageal reflux disease (GORD) in Australian general practice patients.
Miller G; Wong C; Pollack A
Aust Fam Physician; 2015 Oct; 44(10):701-4. PubMed ID: 26484482
[TBL] [Abstract][Full Text] [Related]
3. Infant gastro-oesophageal reflux disease (GORD): Australian GP attitudes and practices.
Kirby CN; Segal AY; Hinds R; Jones KM; Piterman L
J Paediatr Child Health; 2016 Jan; 52(1):47-53. PubMed ID: 26257315
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
10. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
[TBL] [Abstract][Full Text] [Related]
11. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
13. Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.
Jones R; Bytzer P
Aliment Pharmacol Ther; 2001 Jun; 15(6):765-72. PubMed ID: 11380314
[TBL] [Abstract][Full Text] [Related]
14. Gastro-oesophageal reflux disease--impact of guidelines on GP management.
Kirby CN; Piterman L; Nelson MR; Dent J
Aust Fam Physician; 2008; 37(1-2):73-7. PubMed ID: 18239758
[TBL] [Abstract][Full Text] [Related]
15. GORD.
Miller G; Charles J
Aust Fam Physician; 2009 Dec; 38(12):955. PubMed ID: 20369145
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
17. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties.
Luetzenberg FS; Jiang N
Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137
[TBL] [Abstract][Full Text] [Related]
18. National Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis.
Gilani S; Pynnonen MA; Shin JJ
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):627-33. PubMed ID: 27281111
[TBL] [Abstract][Full Text] [Related]
19. Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study.
MacFarlane B; Matthews A; Bergin J
Int J Clin Pharm; 2015 Oct; 37(5):851-6. PubMed ID: 25972205
[TBL] [Abstract][Full Text] [Related]
20. Anti-reflux medication use in preterm infants.
Binti Abdul Hamid H; Szatkowski L; Budge H; Ojha S
Pediatr Res; 2022 Aug; 92(2):520-525. PubMed ID: 34716422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
